Palladyne AI Corp. (PDYN) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. Palladyne AI Corp. is a U.S.-based technology company developing embodied artificial intelligence (AI) software, collaborative autonomy solutions, advanced avionics, and unmanned aerial vehicles (UAVs). The company operates as a single segment, serving aerospace, defense, and commercial/industrial markets. As of June 30, 2026, the company had 49,338,510 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|
| Revenue, Net | $5.78 million | $9.32 million | $2.73 million |
| Net Loss | $(12.33) million | $(24.93) million | $15.27 million (Income) |
| Loss from Operations | $(13.41) million | $(25.33) million | $(15.03) million |
| Operating Expenses | $19.20 million | $34.65 million | $17.75 million |
| Cash and Cash Equivalents | $33.77 million | $33.77 million | $20.15 million |
| Total Assets | $94.39 million | $94.39 million | $95.71 million |
| Working Capital | $43.78 million | $43.78 million | $46.89 million |
| Accumulated Deficit | $(505.73) million | $(505.73) million | $(480.79) million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 470% quarter-over-quarter (Q2 2026 vs. Q2 2025) and 242% year-to-date. This growth is primarily driven by the November 2025 acquisitions of GuideTech, Warnke Precision Machining, and MKR Fabricators, which added engineering services and precision manufacturing revenue streams.
- Operating Expenses: Total operating expenses rose 111% in Q2 and 95% YTD compared to the prior year. Increases were attributed to higher labor costs from acquisitions, expanded headcount, and intangible amortization ($0.71 million YTD) related to acquired assets.
- Net Income Volatility: The company reported a net loss of $24.93 million YTD 2026, compared to a net income of $15.27 million YTD 2025. The prior year income was significantly boosted by a $29.35 million gain on warrant liabilities, whereas the current period saw a $0.23 million loss on warrant liabilities.
- Backlog: Backlog increased to $24.6 million as of June 30, 2026, from $13.9 million at year-end 2025.
Guidance, Outlook, and Risks
- Liquidity: Management believes current cash, cash equivalents, and marketable securities ($43.7 million) are sufficient to fund operations for at least the next 12 months. The company continues to utilize an "at-the-market" (ATM) equity offering program to raise capital.
- Commercialization: The company is in early stages of commercializing its core AI software (Palladyne IQ, SwarmOS). Sales cycles are estimated at 12-18 months or longer. The company has limited commercial history with its software licensing model.
- Acquisition Integration: Significant operational risks exist regarding the integration of the three entities acquired in late 2025, including manufacturing execution and supply chain management.
- Government Dependence: A portion of revenue is derived from government contracts, which are subject to budgetary cycles, shutdowns, and cancellation risks. The company noted delays in collections and contract consummation due to government shutdowns in late 2025.
- Warrant Expiration: deSPAC Public Warrants expire on September 24, 2026. There is no guarantee they will be in the money prior to expiration.
Investor Verification Checklist
- Verify the sustainability of revenue growth post-acquisition and the conversion rate of backlog ($24.6M) into recognized revenue.
- Monitor cash burn rate and the effectiveness of the ATM program in maintaining liquidity beyond the 12-month runway.
- Assess the timeline for commercializing core AI software products (Palladyne IQ/SwarmOS) versus reliance on acquired engineering/manufacturing services.
- Review the status of deSPAC Warrants (PDYNW) expiring in September 2026 and potential dilution or redemption scenarios.
- Track the impact of government shutdowns or budget changes on contract renewals and collections.